ערך בספרים למניה: Phibro Animal Health Corporation (PAHC)

Phibro Animal Health relies on the expertise of dedicated chemists and veterinarians, creating a unique atmosphere of stability within a narrow niche. Business growth is driven by the serial production of vaccines and lucrative B2B deals with large-scale farms, which reduces costs. The current figure stands at 9.55. Market fluctuations in the share price are complemented by data on the streamlined distribution of preparations through a network of regional hubs to ensure uninterrupted supply for farmers.

An analysis of equity is critical for assessing the long-term sustainability of Phibro Animal Health (PAHC). Book value per share is calculated as the difference between total assets and liabilities, divided by the number of outstanding shares. The book value per share trend demonstrates the actual density of net assets without reporting gaps. Such capitalization provides a financial reserve for the robotization of fermentation lines. Plant automation reduces operational risks, strengthening the fundamental value of the business.